Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples

Shotgun metagenomic sequencing (SMg) enables the simultaneous detection and characterization of viruses in human, animal and environmental samples. However, lack of sensitivity still poses a challenge and may lead to poor detection and data acquisition for detailed analysis. To improve sensitivity,...

Full description

Bibliographic Details
Main Authors: Leonard Schuele, Hayley Cassidy, Erley Lizarazo, Katrin Strutzberg-Minder, Sabine Schuetze, Sandra Loebert, Claudia Lambrecht, Juergen Harlizius, Alex W. Friedrich, Silke Peter, Hubert G. M. Niesters, John W. A. Rossen, Natacha Couto
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/12/1358
_version_ 1827701335312564224
author Leonard Schuele
Hayley Cassidy
Erley Lizarazo
Katrin Strutzberg-Minder
Sabine Schuetze
Sandra Loebert
Claudia Lambrecht
Juergen Harlizius
Alex W. Friedrich
Silke Peter
Hubert G. M. Niesters
John W. A. Rossen
Natacha Couto
author_facet Leonard Schuele
Hayley Cassidy
Erley Lizarazo
Katrin Strutzberg-Minder
Sabine Schuetze
Sandra Loebert
Claudia Lambrecht
Juergen Harlizius
Alex W. Friedrich
Silke Peter
Hubert G. M. Niesters
John W. A. Rossen
Natacha Couto
author_sort Leonard Schuele
collection DOAJ
description Shotgun metagenomic sequencing (SMg) enables the simultaneous detection and characterization of viruses in human, animal and environmental samples. However, lack of sensitivity still poses a challenge and may lead to poor detection and data acquisition for detailed analysis. To improve sensitivity, we assessed a broad scope targeted sequence capture (TSC) panel (ViroCap) in both human and animal samples. Moreover, we adjusted TSC for the Oxford Nanopore MinION and compared the performance to an SMg approach. TSC on the Illumina NextSeq served as the gold standard. Overall, TSC increased the viral read count significantly in challenging human samples, with the highest genome coverage achieved using the TSC on the MinION. TSC also improved the genome coverage and sequencing depth in clinically relevant viruses in the animal samples, such as influenza A virus. However, SMg was shown to be adequate for characterizing a highly diverse animal virome. TSC on the MinION was comparable to the NextSeq and can provide a valuable alternative, offering longer reads, portability and lower initial cost. Developing new viral enrichment approaches to detect and characterize significant human and animal viruses is essential for the One Health Initiative.
first_indexed 2024-03-10T14:31:08Z
format Article
id doaj.art-7c0ded7201be45e6a8699120c177d9df
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T14:31:08Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-7c0ded7201be45e6a8699120c177d9df2023-11-20T22:34:04ZengMDPI AGViruses1999-49152020-11-011212135810.3390/v12121358Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical SamplesLeonard Schuele0Hayley Cassidy1Erley Lizarazo2Katrin Strutzberg-Minder3Sabine Schuetze4Sandra Loebert5Claudia Lambrecht6Juergen Harlizius7Alex W. Friedrich8Silke Peter9Hubert G. M. Niesters10John W. A. Rossen11Natacha Couto12Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsIVD Innovative Veterinary Diagnostics (IVD GmbH), 30926 Seelze, GermanyAnimal Health Services, Chamber of Agriculture of North Rhine-Westphalia, 59505 Bad Sassendorf, GermanyAnimal Health Services, Chamber of Agriculture of North Rhine-Westphalia, 59505 Bad Sassendorf, GermanyAnimal Health Services, Chamber of Agriculture of North Rhine-Westphalia, 59505 Bad Sassendorf, GermanyAnimal Health Services, Chamber of Agriculture of North Rhine-Westphalia, 59505 Bad Sassendorf, GermanyDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsInstitute of Medical Microbiology and Hygiene, University of Tübingen, 72076 Tübingen, GermanyDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, 9713 RC Groningen, The NetherlandsShotgun metagenomic sequencing (SMg) enables the simultaneous detection and characterization of viruses in human, animal and environmental samples. However, lack of sensitivity still poses a challenge and may lead to poor detection and data acquisition for detailed analysis. To improve sensitivity, we assessed a broad scope targeted sequence capture (TSC) panel (ViroCap) in both human and animal samples. Moreover, we adjusted TSC for the Oxford Nanopore MinION and compared the performance to an SMg approach. TSC on the Illumina NextSeq served as the gold standard. Overall, TSC increased the viral read count significantly in challenging human samples, with the highest genome coverage achieved using the TSC on the MinION. TSC also improved the genome coverage and sequencing depth in clinically relevant viruses in the animal samples, such as influenza A virus. However, SMg was shown to be adequate for characterizing a highly diverse animal virome. TSC on the MinION was comparable to the NextSeq and can provide a valuable alternative, offering longer reads, portability and lower initial cost. Developing new viral enrichment approaches to detect and characterize significant human and animal viruses is essential for the One Health Initiative.https://www.mdpi.com/1999-4915/12/12/1358next-generation sequencingone healthshotgun metagenomic sequencingporcine virusestargeted sequence captureviral metagenomics
spellingShingle Leonard Schuele
Hayley Cassidy
Erley Lizarazo
Katrin Strutzberg-Minder
Sabine Schuetze
Sandra Loebert
Claudia Lambrecht
Juergen Harlizius
Alex W. Friedrich
Silke Peter
Hubert G. M. Niesters
John W. A. Rossen
Natacha Couto
Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
Viruses
next-generation sequencing
one health
shotgun metagenomic sequencing
porcine viruses
targeted sequence capture
viral metagenomics
title Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
title_full Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
title_fullStr Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
title_full_unstemmed Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
title_short Assessment of Viral Targeted Sequence Capture Using Nanopore Sequencing Directly from Clinical Samples
title_sort assessment of viral targeted sequence capture using nanopore sequencing directly from clinical samples
topic next-generation sequencing
one health
shotgun metagenomic sequencing
porcine viruses
targeted sequence capture
viral metagenomics
url https://www.mdpi.com/1999-4915/12/12/1358
work_keys_str_mv AT leonardschuele assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT hayleycassidy assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT erleylizarazo assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT katrinstrutzbergminder assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT sabineschuetze assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT sandraloebert assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT claudialambrecht assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT juergenharlizius assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT alexwfriedrich assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT silkepeter assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT hubertgmniesters assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT johnwarossen assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples
AT natachacouto assessmentofviraltargetedsequencecaptureusingnanoporesequencingdirectlyfromclinicalsamples